ライフサイエンスコーパス: clonogenic

1 tegrin and DLL1 and were highly adhesive and clonogenic.

2 lls showed significantly increased soft-agar clonogenic ability and tumor sphere formation.

3 This is associated with acquisition of clonogenic ability by fused cells.

4 romotes cell proliferation and increases the clonogenic ability in breast cancer cells.

5 The clonogenic ability of CaP cells expressing Lin28 was det

6 nal cancer cell lines reduced cell invasion, clonogenic ability, and epithelial-mesenchymal transitio

7 significantly inhibited their proliferation, clonogenic ability, and invasiveness by suppressing extr

8 litaxel-induced senescence, with the loss of clonogenic ability, and the induction of senescence-asso

9 n-1-silenced cells rescued cell motility and clonogenic ability.

10 icity under limiting dilution conditions and clonogenic activity in soft agar.

11 that persistent HGF treatment stimulates the clonogenic activity of ICAM1-positive luminal progenitor

12 used by two mechanisms: (1) decreases in the clonogenic activity of the stem cells and in the endocri

13 ll divisions demonstrates that the increased clonogenic activity resides within the undivided fractio

14 ibited enhanced cell proliferation, elevated clonogenic activity, accelerated anchorage-independent g

15 IV p17 protein variants with enhanced B-cell clonogenic activity.

16 cancer cells, this protein is necessary for clonogenic activity.

17 These MDS HSCs demonstrated dysplastic clonogenic activity.

18 urthermore, DCA treatment also abrogated the clonogenic advantage conferred by IDH1 mutation.

19 cally defined as undifferentiated and highly clonogenic ALDH(+)/CD49f(+)/EpCAM(+) luminal progenitors

20 en directly from patients as well as in vivo clonogenic ALL xenograft cells, destroyed the in vivo cl

21 igh nuclear membrane fluctuations are highly clonogenic and also exhibit gene, protein, and functiona

22 apable of propagating tumor growth in both a clonogenic and an orthotopic serial transplantation assa

23 epressed miR, is inhibitory to Ewing Sarcoma clonogenic and anchorage-independent cell growth, even a

24 ing Sarcoma, and that its depletion inhibits clonogenic and anchorage-independent growth in multiple

25 Clonogenic and differentiation/proliferation assays demo

26 tured human pancreatic tumor cell line using clonogenic and DNA damage assays.

27 Consistently, Pten silencing exacerbated the clonogenic and invasive potential of Tp53-deficient bone

28 We found PIP4K2A to be essential for the clonogenic and leukemia-initiating potential of human AM

29 mia cells can de-differentiate and reacquire clonogenic and leukemogenic properties.

30 ization by GPx2 is essential for maintaining clonogenic and metastatic capacity, but also for the gen

31 Furthermore, these cells showed clonogenic and multilineage differentiation capacities.

32 Migrating cells were highly clonogenic and multipotent and expressed markers associa

33 fetal c-kit-positive CSCs are self-renewing, clonogenic and multipotent in vitro and in vivo.

34 essing cells in adult sheath tissues possess clonogenic and multipotent properties comparable to thos

35 stics of stem cells: they are self-renewing, clonogenic and multipotent.

36 ALDH(hi) cells also exhibited greater clonogenic and organoid-forming capacity compared with A

37 ghput microscopy, allowing analyses of their clonogenic and proliferative capacity.

38 CDC25A inhibition reduces the clonogenic and proliferative potential of JAK2(V617F)-ex

39 By contrast, the clonogenic and repopulating potential of normal hematopo

40 In addition, purified Axin2(lacZ) cells were clonogenic and self-renewing in culture in a Wnt-depende

41 human DF-derived epithelial cells possessed clonogenic and sphere-forming capabilities, as well as e

42 nstrate that Notch3 is expressed in a highly clonogenic and transiently quiescent luminal progenitor

43 th the highest Wnt activity exhibited higher clonogenic and tumorigenic potential than pCCSCs with th

44 Comet, clonogenic, and WST-1 assays showed that KLF8 expression

45 to CCPM-(177)Lu radiotherapy as measured by clonogenic assay (p<0.05).

46 ulfiram-induced toxicity was investigated by clonogenic assay after treatment of human SK-N-BE(2c) ne

47 mesoderm-derived femur/tibia HSCs, including clonogenic assay and long-term culture.

48 Clonogenic assay experiments are frequently used to dete

49 Clonogenic assay for CFU- granulocyte-monocyte suggested

50 tional dose rate radiation using a classical clonogenic assay in murine pancreatic cancer cell lines.

51 this, radiation sensitivity, as measured by clonogenic assay of cultured murine (GL261) and human (U

52 The soft agar clonogenic assay showed that T80/KLF8 cells formed signi

53 n two lung cancer cell lines and performed a clonogenic assay to examine their role in cell prolifera

54 In a clonogenic assay, 19 showed an HCR of 4090 in HT29 cells

55 Cytotoxicity studies, clonogenic assay, flow cytometry and confocal imaging we

56 inhibits NHEJ and cell survival assessed by clonogenic assay.

57 The surviving fraction was determined in a clonogenic assay.

58 We evaluated cell survival by a clonogenic assay; apoptosis by Annexin V immunofluoresce

59 In addition, proliferative and clonogenic assays also show that OTUB1 can enhance the p

60 gemcitabine-mediated cell death assessed via clonogenic assays and cleaved caspase 3 expression.

61 nd/or radiation that were not apparent in 2D clonogenic assays but that may significantly influence t

62 Results from clonogenic assays demonstrated hypersensitivity of SelH

63 Clonogenic assays in HTB9 cells further confirmed that b

64 Radiosensitivity parameters determined by clonogenic assays of mCRC cell lines HT-29 and DLD-1 aft

65 While clonogenic assays soon fell out of favour due to their h

66 forming unit (BFU-E and CFU-E) colonies, the clonogenic assays that quantify early and late erythroid

67 ive clustering and guide-gene selection, and clonogenic assays to delineate hierarchical genomic and

68 ation, decreased colony-forming potential in clonogenic assays, and delayed disease onset in a mouse

69 cing, FACS purification, and robust in vitro clonogenic assays, have changed our view of their roles

70 low cytometry, cell-sorting, and single-cell clonogenic assays, we identified Lin(-)CD34(+)CD38(+)CD4

71 Using flow cytometry and clonogenic assays, we showed that inhibiting autophagy w

72 g unit MK cell numbers twofold vs control in clonogenic assays, without substantially modifying MK ma

73 cose (glycolytic inhibitor) was evaluated in clonogenic assays.

74 combination therapy was assessed by MTS and clonogenic assays.

75 nt CC-RCC in multiple genetic backgrounds by clonogenic assays.

76 in HNSCC cells following EphB4 knockdown in clonogenic assays.

77 effectively targeted and eliminated in vivo clonogenic BPL xenograft cells, even at femtomolar-picom

78 with ovarian cancer metastasis, and reduced clonogenic cancer cell survival.

79 geting miR-126 in LSCs and LPs reduced their clonogenic capacity and eliminated leukemic cells, again

80 ate, stem/progenitor cell marker content and clonogenic capacity in the explants but also had the opp

81 cell marker (p63alpha and ABCG2) content and clonogenic capacity in the explants but had opposite eff

82 ncNB1 knockdown abolishes neuroblastoma cell clonogenic capacity in vitro and leads to neuroblastoma

83 CCA cells inhibited their proliferation and clonogenic capacity in vitro, and suppressed tumor xenog

84 or medium conditioned by them, increased the clonogenic capacity of colonospheres.

85 nt for MOF acetyltransferase activity in the clonogenic capacity of HSCs and progenitors.

86 differentiated tumor cells and supported the clonogenic capacity of KIT(+) colonosphere cells.

87 lted in chromosomal imbalances and increased clonogenic capacity of liver progenitor cells (LPCs) and

88 rescence-based screen, reduced viability and clonogenic capacity of melanoma cell lines and increased

89 y induction of differentiation and decreased clonogenic capacity of myeloid blasts.

90 apamycin (mTOR) with rapamycin increases the clonogenic capacity of primary human oral keratinocytes

91 se-3 by a compound, NSC321205, increases the clonogenic capacity of primary oral keratinocytes and ca

92 , a noncleavable isoform of HuR promotes the clonogenic capacity of primary oral keratinocytes and de

93 ted by functional analysis, hPFCs harbor the clonogenic capacity of PSC cultures and emerge prior to

94 tumor xenografts and this contributed to the clonogenic capacity of the tumor cells.

95 ysplasia proliferated less, showed decreased clonogenic capacity, and formed fewer capillary-like net

96 tendon stem cell marker CD146 and exhibited clonogenic capacity, as well as multilineage differentia

97 alization of radical oxygen species restored clonogenic capacity.

98 leted isoforms in vitro reduces myeloid cell clonogenic capacity.

99 cell (LIC) populations, and suppresses their clonogenic capacity.

100 Thus, PDGFRalpha demarcates the clonogenic cardiogenic Sca1(+) stem/progenitor cell.

101 POR reduced SN30000 reductive metabolism and clonogenic cell death and similarly reduced sensitivity

102 dose rate irradiation more potently induces clonogenic cell death than conventional dose rate irradi

103 R-dependent radiosensitivity as a measure of clonogenic cell death.

104 3K inhibitor BKM120, as evidenced by reduced clonogenic cell growth and three-dimensional (3D) sphero

105 BMP receptor antagonists also decreased clonogenic cell growth.

106 Clonogenic cell kill after treatment with disulfiram con

107 Clonogenic cell killing and reductive metabolism of PR-1

108 of p16 on radiosensitivity was determined by clonogenic cell survival and tumor growth delay assays.

109 A clonogenic cell survival assay confirmed that these drug

110 ons using the CellTiter-Glo luminescence and clonogenic cell survival assays.

111 mal) doses that yielded equivalent levels of clonogenic cell survival.

112 educed TRAIL-induced apoptosis and increased clonogenic cell survival.

113 published high-throughput and high accuracy clonogenic cell-survival data for therapeutic scanned pr

114 rectly sorted (uncultured) or a single-cell (clonogenic) cell population from primary tissue can diff

115 hnology for the generation of 'libraries' of clonogenic cells from 1-mm-diamter endoscopic biopsy sam

116 Destruction of clonogenic cells in the crypt following irradiation are

117 nin alone results in the formation of highly clonogenic cells that are nonmotile and prone to undergo

118 ls represent a highly enriched population of clonogenic cells--notably, the isolated cells exhibited

119 Here, using a clonogenic coculture growth system and a xenograft mouse

120 e reversion of EMT, the loss of TIC-mediated clonogenic colony formation, and the loss of cell motili

121 consistent with a decrease in the number of clonogenic colony-forming unit-fibroblasts within the BM

122 Clonogenic culture of isolated single Bmi1(+) ISCs yield

123 methods previously employed to fit the same clonogenic data.

124 The main effector mechanism of the clonogenic death induced by mir-145 was that of accelera

125 ipheral T cells, but lacked proliferative or clonogenic effects on lung cancer cells.

126 ucosal damage occurs through decline in stem/clonogenic epithelial cell loss mediated by microvascula

127 re somatic mutations, leading to disease and clonogenic evolution.

128 Hep3B and Huh7) increased tumor cell growth, clonogenic formation, migration and invasion, whereas kn

129 c ALL xenograft cells, destroyed the in vivo clonogenic fraction of ALL blast cells, and, at nontoxic

130 ockdown breast cancer cells, suggesting that clonogenic function is served by either CRD-BP isoform.

131 strate the cloning and propagation of highly clonogenic, 'ground state' stem cells of the human intes

132 ells (LT-HSC) in vitro resulted in dispersed clonogenic growth and expression of genes involved in mi

133 inhibits cellular growth, wound healing and clonogenic growth and induces apoptosis of H295R cells i

134 ent (TME) may similarly influence tumor cell clonogenic growth and self-renewal.

135 ally replaced RhoA with respect to invasion, clonogenic growth and survival.

136 HCC models showed reduced proliferation and clonogenic growth behavior following TGF-beta stimulatio

137 a significant decrease in cell viability and clonogenic growth in a dose-dependent manner.

138 specifically induced cell death and reduced clonogenic growth in BMSC-adherent myeloma cell lines, a

139 mewhat, and a significant 3-fold increase in clonogenic growth in soft agar was also noted.

140 Prox1-GFP(+) cells exhibited sustained clonogenic growth in vitro, and lineage-tracing of Prox1

141 knockdown of beta-catenin also abrogates the clonogenic growth of AE(+) mouse HSPCs and human leukemi

142 ow expression levels, CRD-BP is required for clonogenic growth of breast cancer cells.

143 was sufficient to enhance cell migration and clonogenic growth of FTE cells.

144 The clonogenic growth of human colony-forming units was also

145 uced pronounced apoptosis in and reduced the clonogenic growth of multiple AML lines and primary AML

146 allopian tube secretory epithelial cells and clonogenic growth of ovarian cancer cells overexpressing

147 icacy of PI3K/mTOR inhibition in suppressing clonogenic growth of ovarian cancer cells with GAB2 over

148 efficacy of the KAT inhibitors in decreasing clonogenic growth of primary AML patient samples.

149 Finally, we show that the clonogenic growth of primary murine MLL-AF9-expressing l

150 estigated its role in promoting invasion and clonogenic growth of uveal melanoma cells.

151 cle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identi

152 Tumor regrowth indicates that clonogenic growth potential is continually maintained, b

153 IIIc suppressed apoptotic activity, enhanced clonogenic growth, and induced disintegration of the blo

154 be a mediator of mutant p53 GOF activity in clonogenic growth, architectural tissue remodeling, migr

155 the impairment of anchorage-independent and clonogenic growth, consistent with an oncogenic function

156 c cell lines and efficiently abrogates their clonogenic growth.

157 equire laminin binding to beta1-integrin for clonogenic growth.

158 fect on breast cancer cell proliferation and clonogenic growth.

159 NK1A1 attenuates PDAC cell proliferation and clonogenic growth.

160 otoxicity, without adversely affecting human clonogenic hematopoietic progenitors in vitro, or murine

161 bolism pathways induces oxidative stress and clonogenic killing in HNSCCs and this strategy may be us

162 8 years) are significantly more sensitive to clonogenic killing mediated by platinum-based chemothera

163 survival and induced differentiation of the clonogenic leukemia-initiating cells.

164 and host-derived mature hematopoietic cells, clonogenic lineage-committed progenitors and HSCs.

165 epithelial-to-mesenchymal transition to form clonogenic, long-term, self-renewing MSC-like cells.

166 , and demonstrate that this subset of highly clonogenic luminal progenitors is required for mammary g

167 to CD105(+)CD90(+)CD73(+)CD31(-) multipotent clonogenic mesodermal precursors, which can be isolated

168 associated with changes in the frequency of clonogenic MM cells and the progression-free survival of

169 rging strategy targeting mature and immature clonogenic myeloma cell populations in the autograft.

170 e and human, did not adversely impact either clonogenic or multilineage differentiation potential, in

171 terminal bronchioles and exhibited enriched clonogenic organoid growth activity.

172 -inhibitor-induced multinucleated cells fail clonogenic outgrowth, and high percentages of multinucle

173 helial cells renders these cells amenable to clonogenic outgrowth.

174 herapy, because the preleukemic early thymic clonogenic population needs to be eradicated and its dis

175 ividual cells correlates with differences in clonogenic potential and lineage-specific differentiatio

176 lation within Met-pos neurospheres displayed clonogenic potential and long-term self-renewal ability

177 Of note, Sox2(+) stem cells and clonogenic potential are drastically increased in the mu

178 uced with BCR-ABL1 display slowed growth and clonogenic potential as compared to Fyn wild-type BCR-AB

179 ts or with hepatocyte growth factor restored clonogenic potential in low Wnt activity colon cancer ce

180 The new compounds strongly inhibit the clonogenic potential of acute leukemia cell lines.

181 highest in cells with high Wnt activity and clonogenic potential of cells with low Wnt activity were

182 te to the potent effects of FL118 to inhibit clonogenic potential of colon cancer cells.

183 ET bromodomain inhibitor (+)-JQ1 reduced the clonogenic potential of FA patient HSPCs but rescued phy

184 fter uptake, and maintained the survival and clonogenic potential of HSPCs, presumably by preventing

185 17F) inactivation/downregulation and impairs clonogenic potential of Jak2(V617F) cell lines and PV bu

186 bsence of IL2Rgamma completely abrogated the clonogenic potential of JAK3(A572V), as well as the tran

187 trongly triggered apoptosis and impaired the clonogenic potential of leukemic, but not normal, CD34(+

188 ng potential of human AML cells, and for the clonogenic potential of murine MLL-AF9 AML cells.

189 s well as reduction in the proliferative and clonogenic potential of PCa cells.

190 mportantly, PIP4K2A is also required for the clonogenic potential of primary human AML cells.

191 Plk1 inhibitors decreased proliferation and clonogenic potential of prostate cancer cells.

192 thermore, dinaciclib potently suppressed the clonogenic potential of relapsed NRI AMLs in vitro and p

193 he YAP/TAZ co-activators, which maintain the clonogenic potential of these cells.

194 ny assay showed that PLK1 silencing impaired clonogenic potential of TNBC cell lines.

195 H2A ubiquitination activity of PRC1 and for clonogenic potential of U2OS cells.

196 ant, is per se sufficient to confer a B-cell clonogenic potential to the viral protein and modulate,

197 SCF prevented loss of clonogenic potential under differentiation-inducing cond

198 mostly quiescent and associated with higher clonogenic potential when cocultured with BM stromal cel

199 eases cellular viability, proliferation, and clonogenic potential while not altering the proliferatio

200 diated DNA damage response, attenuated their clonogenic potential, abrogated camptothecin (CPT)-induc

201 ts in reduced miR-155-induced proliferation, clonogenic potential, and increased apoptosis.

202 ignificantly inhibited the proliferation and clonogenic potential, and induced apoptosis of drug-resi

203 including androgen deprivation, exhibit high clonogenic potential, and possess long-term tumor-propag

204 -ErbB receptor inhibitor, diminished growth, clonogenic potential, anoikis resistance and induced apo

205 sufficient to reduce malignant cell growth, clonogenic potential, glucose consumption, lactate secre

206 in these cell lines reduced cell growth and clonogenic potential, whereas inhibition of miR-223 incr

207 ular matrix remodeling enzymes, and impaired clonogenic potential.

208 cyte/macrophage differentiation and enhances clonogenic potential.

209 cant reduction of RAS-GTP levels and of cell clonogenic potential.

210 pathways in PDAC cell lines inhibited their clonogenic potential.

211 s, and CD45(+)CD34(+) blood progenitors with clonogenic potential.

212 suppresses both normal and CML HSC long-term clonogenic potential.

213 o evaluate the impact of this miRNA on their clonogenic potential.

214 robust neuronal differentiation and inhibits clonogenic potential.

215 NT61 resulted in decreased proliferation and clonogenic potential.

216 end on CXCR7 for proliferation, survival and clonogenic potential.

217 : 1) increased drug resistance; 2) increased clonogenic potential; 3) activation of both Wnt and Hedg

218 dysplastic cells, which exhibited different clonogenic potentials.

219 rogenitor cells, observing GFP expression in clonogenic progenitor colonies and peripheral blood leuk

220 inhibitor, LY-294002, caused a reduction in clonogenic progenitor number in HPIP-expressing CD34(+)

221 Specification of the clonogenic progenitor of CD8alpha(+) cDCs (the pre-CD8 D

222 ted large numbers of growth factor-dependent clonogenic progeny.

223 ion of miR-28 impairs cell proliferation and clonogenic properties of BL cells by modulating several

224 s validation in comparison with conventional clonogenic radiation survival analysis.

225 PKM2 deletion ablated this clonogenic rescue; thus, IB5 activated a latent cytoprot

226 gs establish quiescent cells as an effective clonogenic reserve and provide a motivation for investig

227 human neuroblastomas and is required for the clonogenic self-renewal and tumorigenicity of human neur

228 and non-SP cells, where transitions between clonogenic states are modulated by exosome-mediated Wnt

229 liferation rates, and greater induction of a clonogenic, stem-like cell population compared with fema

230 Clonogenic studies indicate that polygamain effectively

231 In clonogenic studies this level of release resulted in cyt

232 olonged growth inhibition as well as reduced clonogenic survival (loss of reproductive capacity) but

233 Results: Clonogenic survival after external-beam radiotherapy was

234 39H1 delays the repair of HC DNA and reduces clonogenic survival after ionizing irradiation.

235 nse where biological dose-weighting based on clonogenic survival alone was insufficient.

236 ds to an increase in apoptosis and decreased clonogenic survival and again correlates with APAK expre

237 ting in a decrease in cell proliferation and clonogenic survival and an increase in apoptosis.

238 It also impacted clonogenic survival and anchorage-independent proliferat

239 Here, using gene knockdowns and clonogenic survival and cell viability assays, we demons

240 ant cells resulted in reduced proliferation, clonogenic survival and delayed G(1)-S transition.

241 MKP1 silencing reduced clonogenic survival and enhanced radiosensitivity in the

242 adiosensitization was evidenced by decreased clonogenic survival and increased DNA double-strand brea

243 Inhibition of NF-kappaB reduced clonogenic survival and induced apoptosis and cytostasis

244 accelerated cellular proliferation, improved clonogenic survival and reduced apoptosis, all of which

245 (IR) and etoposide treatment, as assessed by clonogenic survival and short-term proliferation assays.

246 Match oligonucleotides significantly reduced clonogenic survival and upregulated the DNA damage marke

247 In addition, TIMP1 played a role in tumor clonogenic survival and vascular density, while TIMP1 in

248 rix metalloproteinase expression, as well as clonogenic survival and viability during exposure to flu

249 oxyuridine incorporation, Ki-67 staining and clonogenic survival assay.

250 nhanced radiosensitivity as determined via a clonogenic survival assay.

251 d AH63 as supra-additive radiosensitisers by clonogenic survival assays and isobologram analyses.

252 Quantification of DNA breaks and clonogenic survival assays confirm a role for TDP1 in re

253 Clonogenic survival assays demonstrated enhanced killing

254 Cell viability and clonogenic survival assays showed that t-DARPP increased

255 ved glioblastoma cell lines, we confirmed by clonogenic survival assays that GSCs were significantly

256 spectively, induced significant decreases in clonogenic survival compared to either drug alone in FaD

257 ro cell lines treated with (177)Lu-DOTATATE, clonogenic survival decreased and gammaH2AX foci increas

258 The combination index for clonogenic survival following radiation and rucaparib tr

259 cess selected for 22Rv1-cells with increased clonogenic survival following subsequent radiation expos

260 tion as seen by decreased cell viability and clonogenic survival in all pancreatic cancer cell lines

261 1 was obligatory for AR-dependent growth and clonogenic survival in both hormone-dependent PC and cas

262 bining MnPs and AscH- synergized to decrease clonogenic survival in human pancreatic cancer cells.

263 d EIF1AX proteins promoted proliferation and clonogenic survival in LGSC cells, providing the first e

264 PSMA-specific cellular uptake and decreased clonogenic survival in PSMA+ PC3 PIP cells and caused si

265 s, targeting MUC1-C inhibited the growth and clonogenic survival of both trastuzumab-resistant cells.

266 human mesenchymal stem cells and diminished clonogenic survival of cancer cells.

267 In addition, RIP1 silencing rescued clonogenic survival of cells treated with the combinatio

268 bitor or dominant-negative N17Rac1 abrogates clonogenic survival of HFR-selected breast cancer cells

269 F2 knockdown on proliferation, motility, and clonogenic survival of HIF2-dependent tumor cells in vit

270 CYP24A1 degradation reduced clonogenic survival of mutant KRAS-driven lung cancer ce

271 The clonogenic survival of these cells was measured after ex

272 AT3 knockdown on proliferation, motility and clonogenic survival of tumor cells in vitro is phenocopi

273 ls were treated by cisplatin and T2AA, their clonogenic survival was significantly less than that of

274 time, the cellular bioenergetic function and clonogenic survival were largely restored in some cells.

275 r which the number of gammaH2AX foci and the clonogenic survival were measured.

276 Cellular uptake and clonogenic survival were tested in PSMA-positive (PSMA+)

277 ed H2A histone family member X staining) and clonogenic survival were tested in PSMA-positive (PSMA+)

278 exhibited increased DNA damage and decreased clonogenic survival when compared with PSMA- PC3 flu cel

279 oxygen species levels, rate of apoptosis and clonogenic survival, and growth in immune and nonimmune

280 transcription of DNAPK and RAD54, increases clonogenic survival, and increases resolution of DNA dou

281 nhancing glioblastoma cell proliferation and clonogenic survival, as synemin RNA interference decreas

282 a significant reduction in growth rate, and clonogenic survival, coinciding with the degree of knock

283 lted in radiosensitivity, as seen by reduced clonogenic survival, enhanced apoptotic activity and enh

284 /= 50 nM) significantly decreased viability, clonogenic survival, migration, and invasion of glioblas

285 verified the compounds by in vitro assays of clonogenic survival, proliferation, and migration and in

286 Despite comparable clonogenic survival, spheroid growth differed significan

287 ization, apoptosis, replication recovery, or clonogenic survival.

288 inhibition impaired replication recovery and clonogenic survival.

289 RCA1 tumor suppressor, resulting in elevated clonogenic survival.

290 in increased cell growth, proliferation and clonogenic survival.

291 by ABT-737 to promote apoptosis and loss of clonogenic survival.

292 ation with increased, rather than decreased, clonogenic survival.

293 lso reduces cell proliferation, motility and clonogenic survival.

294 dation of the mutant form of p53 and reduced clonogenic survival.

295 f senescence, which contributed to decreased clonogenic survival.

296 damage and senescence, leading to decreased clonogenic survival.

297 NA mediated ARID1B depletion, as measured by clonogenic survival.

298 ensitivity of cells and their dose-dependent clonogenic survival.

299 MSCs overexpressing TERT and MYOCD were more clonogenic than mock-transduced MSCs.

300 In a clonogenic tumor cell survival assay, SSRBC surrogate he